ONO-4641

DRUG2 trials

Sponsors

Ono Pharma USA Inc, EMD Serono

Conditions

Multiple Sclerosis

Phase 2

A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis

CompletedNCT01081782

Ono Pharma USA IncMultiple Sclerosis

Start: 2010-03-31End: 2011-12-31Updated: 2013-12-25

Phase 2 Extension Trial in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS)

TerminatedNCT01226745

EMD SeronoMultiple Sclerosis

Start: 2010-10-31End: 2015-01-31Updated: 2016-07-12